Skip to content
Screener

Tempus AI, Inc. TEM Financing Cash Flow

Financing Cash Flow at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$3M-122%
NeoGenomics logo
NeoGenomicsNEO
-$12.24M+94.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$6.24M-36.3%
IQVIA logo
IQVIAIQV
-$214M—
Guardant Health logo
Guardant HealthGH
-$21.58M+67.7%
Natera, Inc. logo
Natera, Inc.NTRA
$3.76M+591%

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M—
CapEx-$22.5M-400%
Free cash flow-$30.1M—

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%—

Returns & leverage

See full
Return on equity-67.4%-16.0pp
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s financing cash flow?
Tempus AI, Inc. (TEM) reported financing cash flow of $97.12M in Q2 2026.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Tempus AI, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude